Comparative Study of Turmeric Extract in Patients With Arthrosis.
A Double-blind, Randomized, Parallel Group, Phase III Comparative Study of Turmeric Extract and Placebo to Patients With Mild to Moderate Arthrosis of the Knee and or Hip.
1 other identifier
interventional
120
1 country
1
Brief Summary
The aim of this study is to test if an extract of Turmeric can alleviate symptoms of osteoarthritis in volunteers with osteoarthritis of the hip and or knee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jan 2020
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 3, 2020
CompletedFirst Posted
Study publicly available on registry
August 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2020
CompletedOctober 25, 2021
July 1, 2020
8 months
January 3, 2020
October 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Pain
Difference in WOMAC pain on a 100 mm VAS scale (high levels worse)
3 month
Pain
Difference in WOMAC pain on a 100 mm VAS scale (high levels worse)
6 month
ADL (Activity of daily living)
Difference in WOMAC ADL on a 100 mm VAS scale (high levels worse)
3 month
ADL (Activity of daily living)
Difference in WOMAC ADL on a 100 mm VAS scale (high levels worse)
6 month
Rescue medication
Consumption of rescue medication from diaries (mg)
3 month
Rescue medication
Consumption of rescue medication from diaries (mg)
6 month
Secondary Outcomes (4)
Stiffness of joints
3 month
Stiffness of joints
6 month
The volunteer evaluation of Global Disease Severity (PGAD)
3 month
The volunteer evaluation of Global Disease Severity (PGAD)
6 month
Other Outcomes (2)
SF-12 (Quality of life)
3 month
SF-12 (quality of life)
6 month
Study Arms (2)
Placebo
PLACEBO COMPARATORone capsule daily
Turmeric extract
ACTIVE COMPARATORone capsule daily
Interventions
Eligibility Criteria
You may qualify if:
- Healthy Volunteers
- years of age or more
- Osteoarthritis of the hip and or the knee
- Suffering from pain in the hip and or knee -
You may not qualify if:
- If volunteers are on a waiting list for hip or knee surgery
- If the volunteers are involved in an other clinical trial
- If the volunteers are taking other herbal remedies, which canhav influende on # Osteoarthritis.
- Abusers of alcohol and drugs
- Volunteers not easy to cope with
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Nutrition, Exercise and Sports
Copenhagen, 1958 Frb. C, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kaj W Hansen, Prof, DMSCi
University of Copenhagen
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- professor, MD, DMsCi
Study Record Dates
First Submitted
January 3, 2020
First Posted
August 5, 2020
Study Start
January 1, 2020
Primary Completion
September 7, 2020
Study Completion
September 7, 2020
Last Updated
October 25, 2021
Record last verified: 2020-07